Nova Patents
AT194657T

Viral defective vaccine produced by transcomplementing cell line.

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

48 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
9020799United KingdomA
9104903United KingdomA
9101632United KingdomW

Members48

Family members, oldest first
DocumentOfficeKind
GB9020799D0United KingdomD0
GB9104903D0United KingdomD0
CA2091678A1CanadaA1
WO9205263A1World Intellectual Property Organization (WIPO)A1
AU8648991AAustraliaA
MX9203717AMexicoA
GB9226172D0United KingdomD0
NO931057D0NorwayD0
FI931309AFinlandA
NO931057LNorwayL
GB9305710D0United KingdomD0
GB9306044D0United KingdomD0
EP0550553A1European Patent Office (EPO)A1
BR9106879ABrazilA
GB2263480AUnited KingdomA
OA09777AAfrican Intellectual Property Organization (OAPI)A
GB9324964D0United KingdomD0
JPH06504194AJapanA
GB2263480BUnited KingdomB
CA2158148A1CanadaA1
WO9421807A2World Intellectual Property Organization (WIPO)A2
AU6261794AAustraliaA
WO9421807A3World Intellectual Property Organization (WIPO)A3
AU658836B2AustraliaB2
EP0689603A1European Patent Office (EPO)A1
JPH08507784AJapanA
US5665362AUnited States of AmericaA
HK1001656A1Hong Kong, ChinaA1
AU696336B2AustraliaB2
US5837261AUnited States of AmericaA
EP0953648A2European Patent Office (EPO)A2
EP0550553B1European Patent Office (EPO)B1
AT194657TThis recordAustriaT
ATE194657T1AustriaT1
DE69132311D1GermanyD1
DK0550553T3DenmarkT3
ES2150416T3SpainT3
DE69132311T2GermanyT2
GR3034484T3GreeceT3
FI110438BFinlandB
US6541009B1United States of AmericaB1
NO314550B1NorwayB1
CA2091678CCanadaC
KR100372934B1Republic of KoreaB1
RU2236256C2Russian FederationC2
JP3895366B2JapanB2
EP0953648A3European Patent Office (EPO)A3
US7374768B1United States of AmericaB1